Viewing nowCombinationSevion HCT Tablet 10/40/12.5mg
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg +1 more
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 201805295 · Approved 2018.12.26 · Insurance code 657806370
Improvement in blood pressure control for essential hypertension
The combination therapy of amlodipine and olmesartan medoxomil is used when blood pressure is not adequately controlled in patients with essential hypertension. Each drug helps to lower blood pressure by dilating the blood vessels, thereby contributing to effective blood pressure control. This therapy is used to reliably improve the blood pressure of patients with hypertension requiring consistent management and reduce cardiovascular risks and prevent complications.
This medication should be taken once daily as one tablet, with or without food, preferably at the same time each day (e.g., in the morning). The recommended dosage is as follows: - 5/20/12.5mg: For patients whose blood pressure is not adequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/40mg.
Safety and efficacy in pediatric patients under 18 years of age have not been established, and its use is not recommended.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals with allergies or hypersensitivity to this medication or its components should not take it. It is safer for pregnant or nursing women to avoid using this medication. Patients with severe hypotension, severe liver or kidney disease, unstable heart failure after acute myocardial infarction, or severe aortic stenosis should not use this medication. Patients with reduced blood volume or decreased sodium may experience hypotension at the beginning of treatment, so they should be monitored closely. This medication may affect kidney function; therefore, patients with poor kidney function should consult a physician before using it. Patients with impaired liver function or liver disease should use caution when taking this medication, and it is not recommended for patients with severe liver disease. Elderly patients or those with a history of specific heart diseases, systemic lupus erythematosus, gout, or hypokalemia should exercise caution when taking this medication. As this medication lowers blood pressure, it may cause dizziness or lightheadedness; caution is required when driving or operating hazardous machinery. While taking this medication, blood pressure, kidney function, and electrolyte levels should be regularly monitored to ensure there are no abnormalities. When using with certain medications (such as lithium, NSAIDs, or other antihypertensives), interactions may occur, so consulting a physician or pharmacist is essential. In cases of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and immediate medical attention must be sought for appropriate treatment. This medication should be stored in a sealed container, protected from moisture, heat, and light, and kept out of reach of children. If pregnant or nursing, it is safer to avoid its use, and it is not recommended for children under 18 years of age.
Rash, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, oral/eye mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at room temperature between 1°C and 30°C. This helps to maintain its efficacy and safety.
Grayish-red round film-coated tablet
28 tablets (14 tablets/PTP×2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg +1 more
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.